Treatment and rehabilitation optimization of patients with COVID-19

Authors

  • O.G. Shekera Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine; International Public Organization "International Association "Health of Society", Kyiv, Ukraine
  • A.K. Duda Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
  • A.R. Vega Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
  • I.V. Manzheleeva Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
  • T.V. Mastepan Kyiv City Clinical Hospital 4, Kyiv, Ukraine
  • V.A. Boyko Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
  • L.P. Kotsyubailo Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
  • A.M. Pechenka Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine

DOI:

https://doi.org/10.22141/2306-2436.9.6.2020.226953

Keywords:

rehabilitation, COVID-19, SARS-CoV-2, recovery

Abstract

Background. During the COVID-19 pandemic, more and more patients need rehabilitation. The purpose of the study is to determine the basic principles of patient rehabilitation at different periods of COVID-19. Materials and methods. The research materials were international literary sources (15 items), international normative documents (3 items). The bibliosemantic method of research, methods of systems approach and content analysis were used. Results. Today, countries around the world are in various stages of a pandemic, and many countries are entering a post-COVID-19 phase. People who suffer from the effects of this disease may face long-term disability and disability. The extent and duration of possible functional impairment and disability are still unknown, but it is clear that these patients will need rehabilitation during all periods of the disease. Persistent symptoms are common with COVID-19, including shortness of breath, chest pain and cough. Physical, psychological (eg, anxiety, depression, post-traumatic stress disorder) and cognitive (eg, memory and concentration impairment) symptoms may occur in some cases. Surveillance focuses on identifying and treating acute complications in the early period of COVID-19, while follow-up focuses on evaluating and treating persistent symptoms. Conclusions. The significant duration of the COVID-19 pandemic has led to an increase in the number of people requiring rehabilitation. Some aspects of convalescence may be unique to COVID-19, but are in many ways similar to those found in other infectious and non-infectious diseases.

References

https://www.nice.org.uk/guidance/ng188.

Carfì A, Bernabei R, Landi F, Gemelli Against ­COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020; 324:603.

https://www.cdc.gov/mmwr/volumes/69/wr/mm6930e1.htm?s_cid=mm6930e1_w#suggestedcitation.

Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 2020.

Bowles KH, McDonald M, Barrón Y, et al. Surviving COVID-19 After Hospital Discharge: Symptom, Functional, and Adverse Outcomes of Home Health Recipients. Ann Intern Med 2020.

https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.

Barman MP, Rahman T, Bora K, Borgohain C. COVID-19 pandemic and its recovery time of patients in India: A pilot study. Diabetes Metab Syndr 2020; 14:1205.

Raghu G, Wilson KC. COVID-19 interstitial pneumonia: monitoring the clinical course in survivors. Lancet Respir Med 2020; 8:839.

Nehme M, Braillard O, Alcoba G, et al. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Ann Intern Med 2020.

Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep 2020; 69:993.

Hopkins C, Surda P, Whitehead E, Kumar BN. Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study. J Otolaryngol Head Neck Surg 2020; 49:26.

Kosugi EM, Lavinsky J, Romano FR, et al. Incomplete and late recovery of sudden olfactory dysfunction in COVID-19. Braz J Otorhinolaryngol 2020; 86:490.

Liu C, Ye L, Xia R, et al. Chest Computed Tomography and Clinical Follow-Up of Discharged Patients with COVID-19 in Wenzhou City, Zhejiang, China. Ann Am Thorac Soc 2020; 17:1231.

Price DR, Mikkelsen ME, Umscheid CA, Armstrong EJ. Neuromuscular Blocking Agents and Neuromuscular Dysfunction Acquired in Critical Illness: A Systematic Review and Meta-Analysis. Crit Care Med 2016; 44:2070.

Rubino F, Amiel SA, Zimmet P, et al. New-Onset Diabetes in Covid-19. N Engl J Med 2020; 383:789

Mikkelsen ME, Still M, Anderson BJ, et al. Society of Critical Care Medicine's International Consensus Conference on Prediction and Identification of Long-Term Impairments After Critical Illness. Crit Care Med 2020; 48:1670.

Published

2021-04-19

Issue

Section

Мedicine